Measles (Rubeola - Measles Virus)
Overview
Plain-Language Overview
Measles (Rubeola) is a highly contagious viral infection that primarily affects the respiratory system and skin. It is caused by the measles virus, which spreads through respiratory droplets when an infected person coughs or sneezes. The illness usually begins with symptoms like high fever, cough, runny nose, and red eyes, followed by a distinctive red rash that spreads across the body. This infection can lead to serious complications, especially in young children and people with weakened immune systems. The virus affects the body's ability to fight infections, making individuals more vulnerable to other illnesses. Vaccination has greatly reduced the incidence of measles, but outbreaks still occur in areas with low immunization rates.
Clinical Definition
Measles (Rubeola) is an acute viral illness caused by the measles virus, a single-stranded, negative-sense RNA virus of the Paramyxoviridae family. It primarily infects the respiratory epithelium and spreads systemically via lymphatic and hematogenous routes. The disease is characterized by a prodrome of fever, cough, coryza, and conjunctivitis, followed by the appearance of Koplik spots on the buccal mucosa and a maculopapular rash that typically starts on the face and spreads downward. The infection causes immune suppression, increasing susceptibility to secondary bacterial infections and complications such as pneumonia and encephalitis. Diagnosis is clinically based but confirmed by detection of measles-specific IgM antibodies or viral RNA by PCR. Measles remains a major cause of morbidity and mortality worldwide, especially in unvaccinated populations.
Inciting Event
Exposure to respiratory droplets from a contagious person during coughing or sneezing initiates infection.
Contact with contaminated surfaces followed by touching the face can facilitate viral entry.
Outbreaks in communities with low herd immunity trigger increased incidence of measles.
Latency Period
The incubation period from exposure to symptom onset is typically 10-14 days.
Prodromal symptoms such as fever and cough appear around day 10 post-exposure.
The characteristic rash develops approximately 14 days after initial exposure.
Diagnostic Delay
Early symptoms mimic common viral illnesses leading to initial misdiagnosis as upper respiratory infection.
Lack of awareness or suspicion in vaccinated populations delays consideration of measles.
Failure to recognize Koplik spots or characteristic rash delays clinical diagnosis.
Limited access to serologic or PCR testing in resource-poor settings contributes to delay.
Clinical Presentation
Signs & Symptoms
High-grade fever lasting 4-7 days is typical.
Cough, coryza, and conjunctivitis constitute the classic triad of prodromal symptoms.
Appearance of Koplik spots 1-2 days before rash onset is a hallmark sign.
A diffuse maculopapular rash develops 3-5 days after prodrome, starting on the face.
Patients often experience malaise, photophobia, and lymphadenopathy.
History of Present Illness
Initial high fever, cough, coryza, and conjunctivitis (the 3 C's) develop over several days.
Koplik spots appear on buccal mucosa 1-2 days before rash onset.
A maculopapular rash begins on the face and spreads cephalocaudally and centrifugally over 3-5 days.
Associated symptoms include photophobia, malaise, and lymphadenopathy.
Fever typically peaks with rash onset and lasts 4-7 days.
Past Medical History
History of incomplete or absent MMR vaccination increases risk of measles.
Previous immunodeficiency or chronic illness may worsen disease course.
Prior nutritional deficiencies, especially vitamin A, can exacerbate severity.
No specific past infections directly predispose but recent exposure to measles cases is relevant.
Family History
No known heritable genetic predisposition to measles infection exists.
Family members may share vaccination status affecting susceptibility.
Clusters of cases in families often reflect shared exposure rather than genetic factors.
Physical Exam Findings
Presence of Koplik spots, which are small, white lesions on the buccal mucosa opposite the molars, is pathognomonic for measles.
A maculopapular rash that begins on the face and spreads cephalocaudally and centrifugally is characteristic.
Conjunctivitis with photophobia and periorbital edema is commonly observed.
Cervical and suboccipital lymphadenopathy may be present.
Fever often exceeds 39°C (102°F) during the acute phase.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of measles is established by the presence of a generalized maculopapular rash lasting more than three days, a history of fever ≥ 101°F (38.3°C), and at least one of the three C's: cough, coryza, or conjunctivitis. The presence of Koplik spots on the buccal mucosa is pathognomonic but may be transient. Laboratory confirmation is achieved by detecting measles-specific IgM antibodies in serum or by identifying viral RNA through RT-PCR from respiratory specimens. Epidemiologic linkage to a confirmed case or outbreak can also support diagnosis.
Pathophysiology
Key Mechanisms
Respiratory droplet transmission of the measles virus leads to infection of respiratory epithelium and subsequent viremia.
Infection of immune cells including dendritic cells and lymphocytes causes systemic dissemination and immunosuppression.
Cell-mediated immune response causes characteristic rash and clearance of infected cells.
Suppression of cell-mediated immunity increases susceptibility to secondary bacterial infections.
Syncytia formation due to viral fusion protein leads to multinucleated giant cells in affected tissues.
| Involvement | Details |
|---|---|
| Organs | Lungs are commonly affected by measles, with potential for pneumonia as a serious complication. |
Skin manifests the characteristic maculopapular rash of measles, reflecting immune response to viral infection. | |
Lymph nodes become enlarged due to immune activation during the acute phase of measles. | |
| Tissues | Respiratory epithelium is the primary site of measles virus entry and replication, leading to respiratory symptoms. |
Lymphoid tissue undergoes depletion and dysfunction during measles, causing immunosuppression and increased infection risk. | |
| Cells | T lymphocytes mediate cellular immune response critical for viral clearance in measles infection. |
Dendritic cells present viral antigens to initiate adaptive immunity against the measles virus. | |
Macrophages phagocytose infected cells and release cytokines contributing to inflammation and viral control. | |
| Chemical Mediators | Interferon-gamma is produced by activated T cells and enhances antiviral immunity during measles infection. |
Interleukin-12 promotes differentiation of naive T cells into Th1 cells, supporting cellular immunity against the virus. | |
Tumor necrosis factor-alpha contributes to inflammation and fever characteristic of measles. |
Treatments
Pharmacological Treatments
Vitamin A
- Mechanism:
Enhances epithelial integrity and immune function to reduce measles severity and complications
- Side effects:
Headache
Nausea
Vomiting
- Clinical role:
First-line
Antipyretics (e.g., acetaminophen, ibuprofen)
- Mechanism:
Reduce fever and alleviate associated symptoms
- Side effects:
Liver toxicity (acetaminophen)
Gastrointestinal irritation (ibuprofen)
- Clinical role:
Supportive
Non-pharmacological Treatments
Maintain adequate hydration and nutrition to support recovery from measles.
Isolate infected patients to prevent transmission of the highly contagious measles virus.
Provide supplemental oxygen and respiratory support if respiratory complications develop.
Prevention
Pharmacological Prevention
Administration of measles vaccine (MMR) is the primary pharmacological prevention.
Post-exposure prophylaxis with immune globulin can reduce severity if given within 6 days of exposure.
Vitamin A supplementation reduces morbidity and mortality in children with measles.
Non-pharmacological Prevention
Isolation of infected individuals to prevent airborne transmission is critical.
Ensuring high vaccination coverage in the community prevents outbreaks.
Public health education on respiratory hygiene reduces spread.
Screening and monitoring of contacts during outbreaks help contain transmission.
Improving nutrition and sanitation reduces disease severity and complications.
Outcome & Complications
Complications
Subacute sclerosing panencephalitis (SSPE) is a rare but fatal late complication.
Measles pneumonia is a leading cause of mortality in measles patients.
Acute encephalitis can cause seizures and permanent neurological damage.
Otitis media can lead to hearing loss if untreated.
Diarrheal dehydration contributes significantly to morbidity in children.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Measles (Rubeola - Measles Virus) versus Rubella (German Measles)
Measles (Rubeola - Measles Virus) | Rubella (German Measles) |
|---|---|
Rash starts on the face and spreads downward, becoming confluent and more intense | Rash begins on the face and spreads rapidly, typically milder and less confluent |
Generalized lymphadenopathy less prominent | Prominent postauricular and occipital lymphadenopathy |
Presence of pathognomonic Koplik spots on buccal mucosa | Absent |
Higher risk of severe pneumonia and encephalitis | Congenital infection causing sensorineural deafness and cardiac defects |
Measles (Rubeola - Measles Virus) versus Scarlet Fever
Measles (Rubeola - Measles Virus) | Scarlet Fever |
|---|---|
Paramyxovirus family RNA virus infection | Group A Streptococcus exotoxin-mediated illness |
Maculopapular, confluent rash without sandpaper texture | Fine, sandpaper-like rash with Pastia lines |
Koplik spots on buccal mucosa | Strawberry tongue with white coating initially |
Fever with gradual onset and prodrome | High fever with abrupt onset |
Measles (Rubeola - Measles Virus) versus Kawasaki Disease
Measles (Rubeola - Measles Virus) | Kawasaki Disease |
|---|---|
Can affect all pediatric ages but more common in young children | Primarily affects children under 5 years |
Rash begins on face and spreads cephalocaudally | Polymorphous rash often involving trunk and extremities |
Koplik spots on buccal mucosa | Strawberry tongue with cracked lips and erythema |
Encephalitis and pneumonia | Coronary artery aneurysms |
Measles (Rubeola - Measles Virus) versus Roseola Infantum (Exanthem Subitum)
Measles (Rubeola - Measles Virus) | Roseola Infantum (Exanthem Subitum) |
|---|---|
More common in older children | Typically affects infants 6-24 months old |
Fever and rash overlap with prodrome | High fever for 3-5 days followed by sudden rash onset |
Rash starts on face and spreads downward | Rose-pink maculopapular rash starting on trunk then spreading |
Present | Absent |
Measles (Rubeola - Measles Virus) versus Drug-induced Hypersensitivity Reaction
Measles (Rubeola - Measles Virus) | Drug-induced Hypersensitivity Reaction |
|---|---|
No recent drug exposure | Recent initiation of new medication |
Non-pruritic confluent maculopapular rash with Koplik spots | Widespread erythematous maculopapular rash often pruritic |
Lymphopenia and leukopenia without eosinophilia | Possible eosinophilia and systemic organ involvement |